Article Text

This article has a correction. Please see:

PDF
Chlamydia testing: where are we now? Recruiting high-risk women to a pilot STI screening trial
  1. Tia Hunjan1,
  2. Sarah R Kerry1,
  3. Rebecca Normansell1,
  4. Philip E Hay2,
  5. Tariq S Sadiq3,
  6. Tim Planche4,
  7. Pippa Oakeshot1
  1. 1Department of Population Health Sciences, St George's University of London, London, UK
  2. 2 Department of G-U Medicine, St George's Hospital, London, UK
  3. 3 Department of Cellular and Molecular Medicine, St George's University of London, London, UK
  4. 4 Department of Microbiology, St George's Hospital, London, UK
  1. Correspondence to Dr Tia Hunjan, Department of Population Health Sciences, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK; tiahunjan{at}gmail.com

Statistics from Altmetric.com

In their topical editorial, Jain and Ison state that ‘testing (for chlamydia) is a crucial part of any effective control strategy’.1 In January 2013 we conducted a pilot study of Chlamydia trachomatis and Neisseria gonorrhoea testing in female students at Lambeth Further Education College, London to assess recruitment to a possible prevention of pelvic infection-2 screening trial.2

Two female general practitioners approached consecutive female students in the common room and asked them to help with a women's health study. We explained that only women aged …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd